These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7980057)

  • 1. [Argyrophilic proteins in the nucleolar organizer in the differential diagnosis of cervical dysplasias and cancer].
    Diadyk EA; Vasilenko IV; Smirnova EA; Raĭkhlin NT
    Arkh Patol; 1993; 55(2):23-7. PubMed ID: 7980057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions in neoplastic and non-neoplastic epithelium of the cervix.
    Agarwal J; Gupta JK
    Indian J Pathol Microbiol; 1997 Apr; 40(2):125-7. PubMed ID: 9257496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nucleolar organizer regions in uterine cervical cancer and its precursor epithelial lesions].
    Wistuba I; Roa I; Araya JC; Villaseca M; Capurro I; Rojo J
    Rev Med Chil; 1993 Oct; 121(10):1110-7. PubMed ID: 8191113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
    Jaworski RC
    Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biometric research in the diagnosis of precancerous states and endocervical cancer].
    Novik VI; Agroskin LS; Papaian GV; Solov'eva LV
    Arkh Patol; 1989; 51(12):45-50. PubMed ID: 2629663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
    Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
    Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytometric characterization of the cell nucleus and nucleolus apparatus in dysplasia and exocervical cancer of the cervix uteri].
    Ievleva NF; Chizhova GV; Tsygankov VI
    Klin Lab Diagn; 2006 May; (5):55-6. PubMed ID: 16827244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis and treatment of cervix dysplasia].
    Höffken H
    Med Welt; 1980 Sep; 31(39):1388-90. PubMed ID: 7453522
    [No Abstract]   [Full Text] [Related]  

  • 11. AgNOR counts as a discriminator of lesions of the endocervix.
    Fiorella RM; Saran B; Kragel PJ
    Acta Cytol; 1994; 38(4):527-30. PubMed ID: 8042416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the AgNOR method to distinguish pseudoepitheliomatous hyperplasia from squamous cell carcinoma.
    Sarda R; Sankaran V; Ratnakar C; Veliath AJ; Prema V
    Indian J Cancer; 1995 Dec; 32(4):169-74. PubMed ID: 8772819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
    Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytomorphologic and morphometric characteristics of the endocervical epithelium during malignant degeneration].
    Novik VI; Agroskin LS; Solov'eva LV
    Vopr Onkol; 1989; 35(6):715-21. PubMed ID: 2750084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar organizer regions in benign and malignant glandular lesions of the cervix.
    Allen JP; Gallimore AP
    J Pathol; 1992 Feb; 166(2):153-6. PubMed ID: 1560315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of atypical reserve cells in smears of patients with premalignant and malignant changes in the squamous and glandular epithelium of the uterine cervix.
    Beyer-Boon ME; Verdonk GW
    Acta Cytol; 1978; 22(5):305-11. PubMed ID: 281835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-cytological characteristics of primary invasive cervical cancer].
    Nikitina NI; Vinokur ML; Nevskaia EA
    Vopr Onkol; 1980; 26(11):54-9. PubMed ID: 7456426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of Langerhans cells in normal epithelium and in epithelial lesions of the uterine cervix.
    Puts JJ; Moesker O; de Waal RM; Kenemans P; Vooijs GP; Ramaekers FC
    Int J Gynecol Pathol; 1986; 5(2):151-62. PubMed ID: 3087896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difficulties in the detection and the diagnosis of carcinoma in situ of the uterine cervix in the presence of associated dysplasia].
    Dargent D; Bremond A; Rudigoz RG; Beau GE
    Nouv Presse Med; 1976 Nov; 5(40):2691-3. PubMed ID: 1005084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of cytological routine checks (author's transl)].
    Scholz A
    Zentralbl Gynakol; 1979; 101(15):958-61. PubMed ID: 532421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.